Alphanox Co.,Ltd.

KOSDAQ:A043100 Rapporto sulle azioni

Cap. di mercato: ₩16.5b

AlphanoxLtd Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Kim Il

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEO4.9%
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Investors Don't See Light At End Of Alphanox Co.,Ltd.'s (KOSDAQ:043100) Tunnel And Push Stock Down 27%

Sep 30
Investors Don't See Light At End Of Alphanox Co.,Ltd.'s (KOSDAQ:043100) Tunnel And Push Stock Down 27%

Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Jun 27
Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Jun 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Feb 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

AMMINISTRATORE DELEGATO

Kim Il (54 yo)

no data

Mandato

Kim Il serves as President and Chief Executive Officer of Solco Biomedical Co. Ltd. and is responsible for Overall Management. In August 1996, Kim Il joined Memory Sales Division at Hyundai Electronic Co.,...